Journal article
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- Publication status:
- In press
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1016/s0140-6736(19)31817-3
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet More from this journal
- Publication date:
- 2019-09-05
- Acceptance date:
- 2019-07-08
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:1054887
- UUID:
-
uuid:dc9fd6d7-053b-4aad-8fa5-8085fa0b5a8d
- Local pid:
-
pubs:1054887
- Source identifiers:
-
1054887
- Deposit date:
-
2019-09-23
- ARK identifier:
Terms of use
- Copyright date:
- 2019
If you are the owner of this record, you can report an update to it here: Report update to this record